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A Fourier-transform ion cyclotron resonance (FT-ICR) top-down mass spectrometry strategy
for determining the adenosine triphosphate (ATP)-binding site on chicken adenylate kinase is
described. Noncovalent protein–ligand complexes are readily detected by electrospray ioniza-
tion mass spectrometry (ESI-MS), but the ability to detect protein–ligand complexes depends
on their stability in the gas phase. Previously, we showed that collisionally activated
dissociation (CAD) of protein–nucleotide triphosphate complexes yield products from the
dissociation of a covalent phosphate bond of the nucleotide with subsequent release of the
nucleotide monophosphate (Yin, S. et al., J. Am. Soc. Mass Spectrom. 2008, 19, 1199–1208).
The intrinsic stability of electrostatic interactions in the gas phase allows the diphosphate group
to remain noncovalently bound to the protein. This feature is exploited to yield positional
information on the site of ATP-binding on adenylate kinase. CAD and electron capture
dissociation (ECD) of the adenylate kinase–ATP complex generate product ions bearing mono-
and diphosphate groups from regions previously suggested as the ATP-binding pocket by
NMR and crystallographic techniques. Top-down MS may be a viable tool to determine the
ATP-binding sites on protein kinases and identify previously unknown protein kinases in a
functional proteomics study. (J Am Soc Mass Spectrom 2010, 21, 899–907) © 2010 American
Society for Mass SpectrometryProteins function in biology through direct inter-action with other molecules. A ligand can be amolecule, an atom, or an ion that binds to a
specific site on the protein by a variety of means,
including hydrogen bonding, Van der Waals interac-
tions, and ionic forces. Determining the presence of
protein–ligand interactions and the structures of protein–
ligand complexes are of critical importance in biol-
ogy, and this knowledge is often essential for efforts
to establish new molecular drug targets and to develop
more potent medicines.
A number of biophysical tools are available to char-
acterize the interaction between a protein and its li-
gand(s). However, mass spectrometry (MS) offers po-
tential advantages in sensitivity, specificity, and speed,
especially compared with high-resolution nuclear mag-
netic resonance (NMR) spectroscopy and X-ray crystal-
lography. With electrospray ionization (ESI) to ionize
macromolecules without disrupting covalent bonds
while maintaining weak noncovalent interactions, the
ESI-MS molecular mass measurement provides direct
evidence for protein–ligand associations. The protein–
ligand interactions are often sufficiently retained upon
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the complex size and binding stoichiometry can be
measured [1–3].
Although binding stoichiometry and, in many exam-
ples, the relative and absolute solution binding affinities
can be measured by ESI-MS methodologies, determin-
ing the precise ligand binding site on a target protein is
not easily tractable using MS directly. Tandem mass
spectrometry (MS/MS) is widely applied to derive the
amino acid sequence of small polypeptides (for exam-
ple, in the so-called bottom-up proteomics approach),
and MS/MS of intact proteins (i.e., top-down MS [4])
show potential to be a tool for protein identification
and elucidation of post-translational modifications [5].
However, the application of top-down MS to access a
protein’s primary structure while preserving noncova-
lent ligand binding would seem to be an insurmount-
able task because of the lability of the protein–ligand
interaction, both in solution and in the gas phase.
However, recent reports suggest that an MS ap-
proach may be useful for pinpointing protein–ligand
binding. Hydrogen-deuterium exchange (HDX) exper-
iments can yield structural information on the regions
of a protein involved in protein–protein and protein–
ligand contacts [6]. Limited proteolysis of protein com-
plexes can sometimes deliver clues on the sites of ligand
binding. For example, we used limited trypsinolysis
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900 YIN AND LOO J Am Soc Mass Spectrom 2010, 21, 899–907with ESI-MS to determine the sites of zinc- and oligo-
nucleotide-binding to a nucleocapsid zinc finger protein
[7]. Our laboratory first demonstrated the application of
top-down mass spectrometry, coupled with electron
capture dissociation (ECD), for determining the binding
site of a small molecule ligand to a protein [8]. Earlier
work by Zubarev and coworkers had suggested that
weak, noncovalent intermolecular bonds could be pre-
served upon ECD [9]. We applied their initial findings
to localize the binding site of a polyamine compound,
spermine, to 13 kDa -synuclein [8]. Spermine had been
demonstrated previously to enhance the propensity of
-synuclein aggregation in Parkinson’s disease. More
commonly employed collisionally activated dissocia-
tion (CAD) for top-down MS readily dissociated the
spermine ligand from the protein. However, using
ECD, the spermine ligand remains bound to specific
c-/z·-product ions to localize spermine binding to the
acidic C-terminal region of the protein. Thus, although
the solution binding association for the -synuclein/
spermine complex is relatively weak (kd  10
3 M),
ligand binding is retained in the gas phase and even
upon ECD [8]. Moreover, these data suggest that many
targeted aspects of the intermolecular associations
formed initially in solution are preserved upon transi-
tion to the gas phase; the spermine binding sites deter-
mined by ESI-ECD-MS overlapped significantly with
those measured by solution NMR.
In this report, we extend our initial studies by
demonstrating that top-down MS with both ECD and
CAD can be used to determine the ligand binding sites
for specific protein–ligand complexes that are particu-
larly stable in the gas-phase, such as the interaction
between proteins and nucleotides. The stability of gas-
phase noncovalent complexes depends highly on the
nature of the binding interactions [8, 10]. For example,
ribonuclease S (RNase S) is a protein complex com-
posed of the 11.5 kDa S-protein and the 2.2 kDa
S-peptide that are noncovalently bound through hydro-
phobic interactions in solution with a kd of ca. 10
9 M.
Maintaining such interactions in the gas phase is diffi-
cult because of the extreme instability of hydrophobic
interactions in a waterless environment [11, 12]. How-
ever, through optimized instrumental parameters to
minimize ion activation in the atmosphere/vacuum
interface of the ESI source, the S-protein/S-peptide
complex can be measured intact by ESI-MS [10, 13, 14].
On the other end of the stability scale, the strength of
electrostatic interactions is significantly enhanced in the
absence of solvent [2, 10, 15–19]. The influence of
solvent on electrostatic interactions and their role in
noncovalent complexes has been described [11, 20, 21].
With covalent-like strength, gas-phase electrostatic in-
teractions are sustained even in CAD MS/MS experi-
ments [10, 19, 22, 23]. For example, RNase A and
cytidine 5=-triphosphate (CTP) form a noncovalent com-
plex (kd  10
6 M) that involves electrostatic interac-
tions. Woods et al. had previously reported on the
enhanced gas-phase stability of phosphate anion inter-actions with basic amino acids found in a number of
peptide systems [16, 17, 19]. Our group recently showed
that CAD-MS/MS of the gas-phase RNase A-CTP com-
plex results in fragmentation of the CTP ligand and
formation of free CMP and RNase A firmly retaining a
diphosphate group as the primary products [10]. The
electrostatic interactions between the diphosphate
group and RNase A are preserved. Such covalent-like
strength of gas-phase electrostatic interactions provides
us with potential opportunities to identify and charac-
terize binding sites of protein–ligand complexes that
involve similarly strong electrostatic interactions. Here,
we show how the stability of electrostatic interactions
can be exploited by top-down mass spectrometry to
determine the adenosine 5=-triphosphate (ATP) binding
site of a protein kinase, adenylate kinase.
Experimental
Materials
Adenosine 5=-monophosphate (AMP), ATP, and ade-
nylate kinase (AK; myokinase, from chicken muscle,
product number M5520) were purchased from Sigma-
Aldrich (St. Louis, MO, USA). All protein samples were
desalted and concentrated with 10 mM ammonium
acetate buffer (pH 6.6), using centrifugal filter devices
(10 kDa MWCO, Amicon Ultra; Millipore Corp., Bil-
lerica, MA, USA). After desalting, ATP was added to a
5 M AK solution in ammonium acetate. The solution
protein and ligand ratio was kept at 1:1.
Mass Spectrometry Experiments
A nanoESI source and Au/Pd coated borosilicate glass
capillaries (Proxeon Biosystems, Odense, Denmark),
with flow rate around 50 nL/min, were coupled to a
7-Tesla LTQ-FT Ultra mass spectrometry (Thermo
Fisher Scientific, San Jose, CA, USA) to acquire positive
ionization mode ESI-MS spectra.
In the source region of the LTQ-FT Ultra, the capil-
lary temperature was set to 210 °C, the capillary voltage
was 45 V, and the tube lens was set to 225 V. The
resolution of the Fourier-transform ion cyclotron reso-
nance (FT-ICR) measurements was established to be
200,000 at 400 mass-to-charge ratio (m/z). The linear ion
trap (LTQ) tuning was optimized to maximize the
signal intensity of the ion at m/z 2160 for the 10-
charged molecule of native AK. The target ion number
for the LTQ and FT-ICR full MS scan was 3  104 and
1  105, respectively. For MS/MS experiments (e.g.,
precursor ion isolation), the target ion number for the
LTQ and FT-ICR was 1  105. Three precursor ion
isolation steps were carried out to optimize isolation of
the targeted precursor ion and to minimize contribu-
tions from nearby ions. The initial isolation window
was set to be centered with a slightly smaller m/z than
the targeted precursor ion and with a wider isolation
width to reduce contamination from higher m/z ions.
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higher m/z to reduce the lower m/z contamination ions.
The last isolation step was centered at the exact m/z of
the targeted precursor with a relative small isolation
window. The isolation width was ca. 10–15 m/z wide.
Contaminations from higher m/z ions were not avoided
completely, but it was kept as low as possible with this
procedure.
Further experimental parameters for top-down MS2
and MS3 are listed in Supplemental Table 1, which can
be found in the electronic version of this article. Top-
down MS/MS were accomplished with CAD or acti-
vated ion ECD (aiECD) in which ECD is coupled with
infrared laser-heating of the product ions. Product ion
yields are enhanced by IR laser-heating after ECD,
consistent with hydrogen bond-retention upon ECD,
but dissociation with further heating [24, 25]. Activated
ion ECD was used effectively for our previous study on
the -synuclein/spermine complex [8]. The 9- and
10-charged apo- and holo-forms of AK were analyzed
with both CAD and aiECD. Further MS3 of AK-pp (AK
bound to a diphosphate group) was carried out with
CAD and aiECD as well. First, the AK-pp precursor ions
were isolated in the LTQ after CAD-MS/MS of AK-ATP.
For CAD of AK-pp, the isolated precursors were frag-
mented in the LTQ and then transferred to the FT-ICR for
detection. For the aiECD experiment, precursors were first
transferred to the FT-ICR cell and then dissociated into
c-/z·-product ions. Product ion mass measurement accu-
racy was generally better than 7 ppm.
Results and Discussion
Kinases are enzymes that transfer a phosphoryl group
from ATP to the hydroxyl groups of proteins or mono-
nucleotides. Phosphorylated proteins and nucleotides
are involved in many biological processes, such as
signaling and maintaining intracellular nucleotide
pools. The interaction between adenylate kinase and
ATP serves as a good model system for our top-down
MS/MS methodology because the ATP-binding sites of
AK have long been investigated by NMR [26, 27], X-ray
crystallography [28–30], and photoactive labeling [31].
AK (ATP:AMP phosphotransferase, EC 2.7.4.3) has a
molecular weight of 21–23 kDa. There are at least five
major families of AK: AK1 is from the cytosol of
mammalian or vertebrate muscles, AK2 is located in
the mammalian mitochondrial intermembrane, AK3 is
from the mammalian mitochondrial matrix, AKe is
found in Escherichia coli, AKy is generated by Saccharo-
myces cerevisiae [27], and a recently reported AK6 minor
family in cell nucleus [32]. The ATP binding sites of
AK have been studied in many different AK fami-
lies, including chicken, human, porcine, rabbit AK1,
and AKe. AK1 from rabbit (KAD1_Rabit), porcine
(KAD1_Pig), and human (KAD1_human) have 93%,
92%, and 92% sequence homology, respectively, to
chicken AK1 (AK1c). AKe (KAD_Ecoli) shares 55%
homology in sequence with AK1c. In this study, AK1cwas used and the amino acids are numbered according
to the AK1c sequence.
CAD-MS/MS of AK, AK-AMP, and AK-ATP
ESI mass spectra for nucleotide-bound AK have been
reported previously [33–36]. Our ESI-FT-ICR-MS and
MS/MS spectra of AK (measured average MW 21,593.8
0.1 Da, expected 21,593.9 Da; Figure 1a), the AK–AMP
complex (measured average MW 21,940.9  0.1 Da,
expected 21,941.1; Supplemental Figure 1a), and the
AK-ATP complex (measured average MW 22,101.2 
0.1 Da, expected 22,101.1 Da; Figure 1b) were acquired
with the LTQ-FT mass spectrometer.
Abundant 1:1 AK–AMP and AK–ATP noncovalent
complexes of relative low charge, 9 and 10, were
measured, consistent with most noncovalent complexes
measured from near neutral pH solutions with ESI-MS.
CAD of the 9 and 10 AK–AMP complexes yielded
primarily the loss of a neutral-charged AMP ligand and
the apo-AK protein (Supplemental Figure 1b). This
behavior is similar to our previous data for CMP-bound
RNase A [10]. However, also consistent with our pre-
viously reported CAD MS/MS spectra measured for
the RNase A-CTP complex [10], CAD of AK-ATP re-
leased AMP and generated the AK-pp complex, i.e., AK
bound to a diphosphate group adduct (H3P2O6), as well
as b-/y-product ions from the polypeptide backbone
(Figure 2 for the 10 precursor, and Supplemental
Figure 2 for the 9 precursor). Figure 3 depicts the
primary dissociation pathways of the AK-ATP frag-
mentation. Also measured in the primary CAD mass
spectra from the AK–ATP complex were b-/y-products
retaining intact ATP and a diphosphate group. MS/MS
of AK-pp from MS3 experiments provide complemen-
tary information about the putative ATP binding sites
to AK. They also provide information about a potential
conformational change of AK upon ATP binding (vide
infra).
Dissociation of the amide bond C-terminal to an Asp
residue was especially prevalent in the top-down CAD
experiments. Other laboratories have reported an un-
usually elevated proportion of dissociation products
C-terminal to Asp residues [37–39]. CAD-MS/MS of the
9 apo-AK (Supplemental Table 2) produced 37 frag-
ments covering 19% of the AK polypeptide sequence.
Within these 37 fragments, there are 8 fragmentation
sites that are particularly abundant, and products from
these sites were measured with more than one charge
state. Six out of these eight abundant fragmentation
sites are from cleavage of the amide bond C-terminal to
an Asp. In CAD-MS/MS of the 10 apo-AK (Figure 2),
12 abundant products are from the C-terminal bond to an
Asp residue. Both 9 and 10 AK-ATP show four abun-
dant fragments in theirMS/MS spectra; most of these sites
originate from the C-terminal bond to an Asp.
A large proportion, greater than 90% in some exam-
ples, of the total signal in the CAD mass spectra of
holo-AK were found in the (AK-pp)n product. Lower
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group, e.g., y100-pp and b180-pp, were observed that
may or may not have resulted from secondary fragmen-
tation of the AK-pp species (Supplemental Figure 2 and
Figure 2).
CAD-MS3 of AK-pp (Figure 4) also generated data to
identify the ATP binding site. Loss of a phosphate
group from AK-pp to generate the AK-p species was
the most abundant product. However, other b-/y-
products with mono- and di-phosphate bound were
measured as well. More importantly, the MS3 data
confirmed the binding site identified from CAD-
MS/MS of AK-ATP. Holo-fragments, including those
retaining either intact ATP or the diphosphate group,
were gathered to plot a map on which an ATP binding
site is found in between amino acid 121-140 (Figure 5).
Results from MS3 of AK-pp confirmed that the diphos-
phate group bound to fragments at the same site as the
ATP. The newly observed y53-pp ion from MS
3 of
AK-pp pinpoints another weaker binding site of the
nucleotide between amino acid 141-180 (Figure 5).
ECD-MS/MS of AK-ATP
Although ECD efficiency can be very high to promote
Figure 1. ESI mass spectra of (a) AK and (b) AK
circles represent multiply charged molecules of
represent the 1:1 AK-ATP complex.top-down MS studies, ECD by itself did not providesignificantly more information about the ligand binding
site for the AK-ATP complex. Precursor ion charge
states affect aiECD experiments significantly because
electron capture cross sections increase quadratically
with charge [40]. For aiECD of the 9-charged holo-AK,
the coverage and number of fragments were at least
50% less than those in aiECD of the 10 precursor
(Supplemental Table 2). No holo-fragments were ob-
served from aiECD of the 9 molecule. Although
aiECD has a much lower fragmentation intensity com-
pared with CAD, it still provided additional valuable
data that verified the ATP binding sites determined by
CAD-MS/MS and MS3 (Figure 5).
Product ions from aiECD-MS/MS originated mainly
from the N-terminal region of the protein, whereas
those from CAD were more evenly distributed along
protein sequence. The aiECD-MS/MS of 10 and 9
ions generated more c-product ions than z·-ions; the
ratio of c- to z·-ions from AK-ATP and AK-pp precur-
sors was observed to be 8.5 and 5, respectively. In
consideration of all MS/MS fragments from both
charge states of apo-AK, the sequence coverage of CAD
and aiECD was found to be 32% and 41%, respectively
(Supplemental Table 2). Combined data of CAD and
aiECD gave nearly 61% sequence coverage of apo-AK,
e presence of ATP. The peaks marked with open
po-protein, and those marked with filled circlesin th
the awhich is much higher than each individual top-down
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from MS/MS of AK-ATP, and MS3 of AK-pp.
In summary, distribution maps of apo and holo
fragments were generated from combined CAD and
aiECD data from both charge states of apo-AK, AK-
ATP, and AK-pp (Figure 5). After comparing the loca-
tion of holo fragments and apo fragments on the
CAD-MS/MS and MS3 map, one primary ATP binding
site is located in between amino acids 121-140, and a
secondary binding site is observed between residues
141-180. ECD data confirms that there is at least one
binding site between residues 94-150. Thus, ECD in this
case did not provide more detailed information about
defining the ligand binding sites, but they directly corrob-
Figure 2. ESI CAD-tandem mass spectra of th
Product ions of the intact apo-protein are mark
marked with the filled circle. Retention of one p
“p”, and retention of two phosphates is labeled
labeled with “p” or “p”, respectively.orate binding regions that were identified by CAD.Dissociation Efficiency of AK and AK-ATP
The CAD efficiency (i.e., generation of detectable prod-
uct ions) was greatly affected by the presence of ATP
ligand binding. Overall sequence coverage of AK from
CAD of the 9 and 10 AK–ATP complex (32%) was
significantly lower than that from CAD of the apo-AK
molecule (14%) (Supplemental Table 2), even though a
slightly higher activation energy was used for CAD of
the holo–AK complex. This sequence coverage behav-
ior may be partially explained by the observation that
a majority of the CAD product ion signal was found
in the (AK-pp)n product rather than distributed
among products resulting from amide backbone bond
-charged (a) AK and (b) AK-ATP 1:1 complex.
open circles, and those of the holo-protein are
ate group by the product ion is represented by
“pp.” The loss or gain of a phosphate group ise 10
ed by
hosph
withcleavages.
AK-A
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sequence informative product ions was not affected by
the presence of ATP ligand binding. Sequence coverage
from aiECD of apo-AK and holo-AK were similar, 41%
and 39%, respectively. Moreover, the total number of
unique product ions generated by aiECD was similar
for both species: 79 for apo-AK and 75 for holo-AK. It is
MS/MS
P P PA
AMPMS/MS
MS/M
S
Figure 3. Dissociation pathways for the
Figure 4. CAD-MS/MS spectrum (MS3) of the 1
for description of labels).not clear if a ligand-induced solution-phase conforma-
tional change suggested for ATP-binding by AK [27, 41,
42] is affecting the dissociation behavior of the gas-phase
AK-ATP complex, i.e., CAD efficiencies are significantly
reduced for the ATP-bound protein, following the conver-
sion from an open to closed conformation with ATP
binding [41, 42]. Based on previous work by others,
holo-product
P P PA
P P
M
S/M
S
holo-product
+
+
apo-product
apo-product
TP complex observed by top-down MS.
K-pp product ion (m/z 2176; see Figure 2 legendP P0 A
-bind
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[45], it should be possible to probe differences in protein
conformation by ECD. However, from our data for AK
and the AK–ATP complex, aiECD efficiencies appear to
dependmore on charge state than conformation; sequence
coverage and the number of products increases from 31%
and 16% for the 9 apo-AK, respectively, to 79% and 41%
for the 10 charge state. (Similar ECD data were mea-
sured for the holo–AK complex.)
ATP-Binding Sites Derived from Solution Phase
and Mass Spectrometry Data
In solution, AK contains two adjacent binding sites with
different binding affinity for ATP and AMP [26, 46].
During the transformation of the phosphoryl group
from ATP to AMP, AK must protect its catalytic center
to avoid transferring the phosphoryl group to free
water. Many studies using a variety of methodologies
since the 1970s have been initiated to determine the
solution phase site of ATP-binding to chicken AK, and
many more have been reported for AKs from other
      MS/MS Apo-AK
      MS/MS AK-ATP
      MS/MS (MS3) AK-pp
N-terminal ions
10 20 30 40 50 60 70 80 900
133 123 113 10193 183 173 163 143153
10 20 30 40 50 60 70 80 900
133 123 113 10193 183 173 163 143153
10 20 30 40 50 60 70 80 900
133 123 113 10193 183 173 163 143153
N-terminal ions
N-terminal ions
(a)
(b)
(c)
Figure 5. Combined product ion distributions
(c) AK-pp measured by CAD and ECD. The b/c
primary sequence line, and the y/z· products a
Product ions that retain a phosphate (p), a dipho
(i.e., holo-products). Bars with two colors indica
CAD or ECD. The ovals span the putative ATPorganisms.From the NMR data of rabbit muscle AK [26], the
triphosphate portion of ATP is bound to K21, L27, and
Q24. Similar conclusions were reached from analysis of
chicken AK, as the side chain of K21 forms hydrogen
bonds with the second and third phosphates of ATP
[47]. Thus, apparently this “essential” lysine plays sev-
eral important structural and functional roles: it stabi-
lizes the phosphate-binding loop (P-loop) and it orients
the triphosphate of ATP to its proper conformation.
X-ray crystallographic studies also strongly suggested
the involvement of several highly conserved arginines,
including R132, R138, R149, R44, R97, and the Gly-loop
(residues 18-23) [27–29, 48].
In addition, R138 cannot be replaced by a lysine
residue, indicating its essential role for catalysis [49].
Photoaffinity-labeling with 8-azidoadenine analogs sug-
gested three possible bindings sites located between resi-
dues K27-L43, T124-E134, and T152-K165 [31]. Analysis
of E. coli AK crystal structures with AMP, ADP, and p1,
p5-di(adenosine 5=)-pentaphosphate (Ap5A) also assign
R44, R97, R132, R149 as key residues for domain closure
and substrate binding [30]. Data from human AK1
C-terminal ions
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13 32333435363738393
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C-terminal ions
the 9 and 10 (a) apo-AK, (b) AK-ATP, and
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presented by the bars below the sequence line.
te (pp), or ATP are represented by the red bars
erlapping apo- and holo-fragments from either
ing regions.1
3
1
3
1
3
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pro
re re
spha
te ovbound to Ap5A shows similar interactions with the
906 YIN AND LOO J Am Soc Mass Spectrom 2010, 21, 899–907phosphate groups of the substrate [50]; human AK1 and
chicken AK1 show 83% sequence identity. Frommost of
the high-resolution structural data, apparently the Gly-
loop (residues 18-23) interacts with the -phosphate
and -phosphate, and R132 and R138 interact with the
-phosphate of ATP [29, 30, 41].
Top-down tandem mass spectrometry of AK-ATP
identifies amino acids 121-140, also known as the “lid-
loop,” to be the primary binding site of ATP to AK1c in
the gas phase. An additional minor site was found also
at residues 141-180. Our gas-phase data support the
conserved arginines’ responsibility for binding ATP.
The Gly-loop near the N-terminus and part of the
solution phase ATP-binding pocket is not implicated by
the mass spectrometry data. However, this may be a
result of the gas-phase process involved in the MS/MS
event. CAD of AK-ATP releases free AMP (containing
the -phosphate) to form the AK-pp species. If the
primary interactions involved in the solution phase
structure are retained in the gas-phase complex, resi-
dues R132 and R138 would be responsible for the
retention of the -phosphate group in the AK-pp com-
plex, and the interaction between the Gly-loop residues
(primarily K21) and the -phosphate may be too weak
in the gas phase to survive the CAD events.
Conclusions
Many examples have been reported in which ESI was
used to deliver a noncovalent protein complex from
solution into the gas phase and was measured intact by
mass spectrometry [2, 51–54]. However, these studies
generally do not address the question whether the
structure of the gas-phase complex is similar to its
initial solution phase structure. Because the phase tran-
sition from solution to the gas phase is not a subtle
effect, it would not be surprising to find some pertur-
bation in the structure of a protein complex upon
removal of solvent. In fact, studies suggest that large
protein complexes undergo a shrinking process as a
result of solvent loss [1]. Therefore, the solution to
Breuker and McLafferty’s question, “For how long,
under what conditions, and to what extent, can solution
structure be retained without solvent?” is not entirely
obvious from reports to date [55].
Our results from the top-down MS analysis of the
gas-phase ATP-bound AK complex are generally con-
sistent with previous data measured by NMR and X-ray
crystallography. The ATP ligand and the AK protein
are in equilibrium in solution, with a dissociation
constant in the micromolar range [34, 35, 56]. Upon
solvent removal to transition into the gas phase, pro-
tein conformation could be rapidly converting into
“new, non-native structures” [55]. Even if the protein’s
conformation is undergoing rapid remolding into a new
structure, for adenylate kinase, however, the ATP li-
gand appears to be fixed to a position dictated by its
solution phase structure. The enhanced gas-phase elec-
trostatic interactions allow the position of the ligandwithin the protein to be locked in place and allow
further probing by tandem MS.
Thus, despite the fact that the solution three-
dimensional structure of a protein complex may not be
completely retained in vacuo, top-down MS may be a
novel, complementary method to higher resolution
structural methods for determining the sites of ligand
binding. We predict that protein–nucleotide complexes
will be especially stable to such MS probing, and that
the method may be useful for determining the sites of
ATP-binding to protein kinases.
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